The Joint Commission and Centers for Medicare & Medicaid Services' (CMS) have defined quality measures for the management of community-acquired pneumonia (CAP) that have both economic and patient care implications. Take this unique opportunity to watch key national thought leaders John Bartlett, MD; Robert Owens Jr., PharmD; Robert Rapp, PharmD; and Andrew Shorr, MD, MPH discuss this critical topic in a CME/CPE certified video webcast:

Program Chairs

John G. Bartlett, MD Professor of Medicine, Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore, Maryland Robert C. Owens, Jr., PharmD Co-Director, Antimicrobial Stewardship Program Clinical Pharmacy Specialist, Infectious Diseases Department of Pharmacy Services and Division   of Infectious Diseases Maine Medical Center Portland, Maine Clinical Assistant Professor Department of Medicine University of Vermont College of Medicine Burlington, Vermont

Robert P. Rapp, PharmD Professor of Pharmacy University of Kentucky College of Pharmacy Professor of Surgery University of Kentucky College of Medicine Associate Director for Clinical Services University Hospital Department of Pharmacy Services Lexington, Kentucky Andrew F. Shorr, MD, MPH Associate Director, Pulmonary & Critical Care Medicine Chief, Pulmonary Clinic Washington Hospital Center (WHC) Washington, DC

Learning Objectives

At the conclusion of this activity, the participants should be able to:

• Explain the significance and impact of community-acquired pneumonia (CAP)
• Describe the most recent trends and the mechanisms of resistance in CAP
• Apply the Joint Commission/CMS Quality Measures for CAP and antibiotic administration
• Explain the evidence-based support for the guidelines and correlate to improving patient outcomes in the clinical setting

Target Audience

This course was designed for managing directors, medical directors, pharmacy directors, Medicaid/Medicare directors and nursing directors who use Group Purchasing Organization contracts for their purchasing functions and wish to identify and implement the best practices to improve operational, economic and clinical performance.

This activity is certified for physicians and pharmacists.

Accreditation Statement

This Activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of CME Consultants and SynerMed® Communications. CME Consultants is accredited by the ACCME to provide continuing medical education for physicians.

In accordance with policy, presenters have indicated if they have a conflict of interest and if so, it has been resolved.

CME Consultants is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation Statement

CME Consultants designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity has been designated for 1.50 contact hour (0.150 CEUs). There will be no fee for this activity. In order to receive credit, all participants must complete an evaluation, request for credit form and a posttest. Statements of Credit will be mailed to participants within six weeks. ACPE #309-999-08-006-H05-P Initial Release Date: December 15, 2008 Planned Expiration Date: December 15, 2009

Method of Participation

To complete the outcomes post-survey and evaluation go to www.CMEUniversity.com. Click on “Find Post-test / Evaluation by Course” on the navigation menu, and search by project JE8034227. Upon successfully completing the survey and evaluation, your certificate will be made available immediately.

Disclosure Statement

In direct response to the September 2004 Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, CME Consultants issued a conflict of interest policy dated January 2, 2005. The policy states that the disclosure of potential financial conflicts of interest within the last 12 months must be made and resolved prior to date of the CME/CE activity where commercial support grants are to be used to fund the activity. The following conflicts have been managed and resolved through CME Consultants Independent Review Committee. Our intent is to assist learners in assessing the potential for bias in information that is presented during the CME/CE activity.

In accordance with Policy, presenters have indicated if they have a conflict of interest and if so, it has been resolved.

Faculty Disclosures

The faculty is also aware it is their responsibility to inform the audience if discussion of any non – FDA approved uses of pharmaceutical, medical equipment, prostheses, etc. will be included in their presentation.

Name	Company and Relationship
John G. Bartlett, MD	Arpida Ltd., Advisory Board Johnson & Johnson, Policy Board Pfizer Inc., Advisory Board
Robert C. Owens, Jr., PharmD	Nothing to disclose.
Robert Rapp, PharmD, FCCP	AstraZeneca, Speakers Bureau Astellas Pharma, Speakers Bureau Ortho McNeil, Consultant, Speakers Bureau Wyeth Pharmaceuticals, Consultant, Speakers Bureau
Andrew Shorr, MD, MPH	Boehringer Ingelheim, Grant Support, Consultant, Speaker GlaxoSmithKline, Grant Support, Consultant, Speaker, Advisory Board Johnson & Johnson, Grant Support, Consultant, Speaker, Advisory Board Pfizer Inc., Grant Support, Consultant, Speaker, Advisory Board Sanofi Aventis, Grant Support, Consultant, Speaker, Advisory Board

Other Disclosures

The planners, managers, and anyone in a position to control the content of CME activities are also required to report any conflicts of interest. The following conflicts have been managed and resolved through CME Consultants’ Independent Review Committee:

Name	Company and Relationship
Jan Schultz, RN, MSN Director, Education Outcomes & Accreditation	Postgraduate Institute for Medicine Nothing to disclose.
Samantha Mattiucci, PharmD Medical Director/Managing Director	CME Consultants, LLC Nothing to disclose.
Michele Ferrucci Project Manager	CME Consultants, LLC Nothing to disclose.
Robin Pearson Vice President, Project Management	SynerMed® Communications Nothing to disclose.
Luciano Acevedo Director, Project Management	SynerMed® Communications Nothing to disclose.
June Basile Assistant Project Manager	SynerMed® Communications Nothing to disclose.
Josh Paul Medical Writer	SynerMed® Communications Alma Lasers, Inc., Consultant/Advisor Biopelle, Inc., Consultant/Advisor

FDA Disclosure Statement

The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Privacy and Confidentiality Statement

CME Consultants has a policy that informs the learner of its Privacy and Confidentiality information as it relates to internet-based CME activities. Go to www.cmeconsultantsinc.com to review in its entirety.

Copyright Statement

©CME Consultants 2008. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or means without prior permission, except for the purposes of references and comment.

Although great care has been taken in compiling and checking the information contained in this Bulletin to ensure accuracy, neither the publisher nor CME Consultants shall be liable for the accuracy of the information or for any errors, omissions, or inaccuracies in this publication.


This activity is:

Presented by the Health Industry Group Purchasing Association.


Jointly sponsored by CME Consultants and SynerMed® Communications.


This activity was made possible through an educational grant provided by Ortho-McNeil administered by Ortho-McNeil Janssen Scientific Affairs, LLC.


Participants must be on a high-speed broadband internet connection to ensure ability to view the streaming video content in this program.

Not already registered?

If you need assistance with your username, password, or with logging in, please call our help desk at 800-763-3978. Click here to run a System Compatibility Check